STOCK TITAN
  1. Home
  2. News
  3. ORHB

ORHUB INC - $ORHB STOCK NEWS

Welcome to our dedicated page for ORHUB news (Ticker: $ORHB), a resource for investors and traders seeking the latest updates and insights on ORHUB stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect ORHUB's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of ORHUB's position in the market.

News
Hippofi Welcomes Scott Bauccio as New Head of Sales for Pur Biologics
Rhea-AI Summary
HippoFi's biotechnology business PUR Biologics announces Scott Bauccio as its new Head of Sales, leveraging his 20 years of sales management to expand sales and distribution channels, securing two new products: PURamnio and PURpeptide. The company aims to strengthen its leadership team and pursue innovation and excellence in the biologic sector, reflecting the first of several strategic actions in 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
22.52%
Tags
none
-
News
HippoFi Ships International Orders and Expects Sales to Exceed $20 Million in the New Year
Rhea-AI Summary
HippoFi's (ORHB) subsidiary, PUR Biologics, has made a significant breakthrough by entering the international market. With a strong distribution network and advanced technologies, the company is poised for substantial sales growth in 2024, targeting a $3.5 billion market for spine surgeries utilizing biological implants. The recent acquisition of activeOrb™ technology further positions the company for success in bone-growth solutions.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
11.31%
Tags
none
-
News
HippoFi Continues to Deliver Sales Growth Adding 14 Major Healthcare Facilities
Rhea-AI Summary
HippoFi's subsidiary, PUR Biologics (ORHB), is expanding its distribution network in California, aiming to provide innovative spine care solutions. With a focus on regenerating bone, cartilage, and spinal discs, PUR Biologics is positioned as a leader in spinal biologics, aiming to capitalize on the growing U.S. market for instrumented spine surgeries worth $3.5 billion annually. The company's expansion reflects its commitment to advancing healthcare technologies and solutions.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
News
Dr. Gail Naughton, World-Renowned Authority in the Multibillion-Dollar Regenerative Medicine Market, Joins HippoFi as the Head of Regenerative Therapeutics and Commercialization
Rhea-AI Summary
HippoFi, Inc. appoints Gail Naughton, a renowned expert in regenerative medicine, as Head of Regenerative Therapeutics and Commercialization. She brings a wealth of experience and a proven track record of success in the industry. Dr. Naughton's expertise will help HippoFi to develop and commercialize regenerative medicine solutions for unmet medical needs.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
19.15%
Tags
none
-
News
International Sales Win for PUR Biologics
Rhea-AI Summary
HippoFi's subsidiary PUR Biologics expands sales globally through robust distribution channels.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-12.81%
Tags
none
-
News
PUR Biologics Secures Innovative Medical Patent with Strong Financial Upside
Rhea-AI Summary
PUR Biologics announces patent acquisition for groundbreaking device to enhance immune response and tap into lucrative medical markets.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
25%
Tags
none
News
HippoFi Announces Strategic Alliance to Lead Spinal Biologics Innovation
Rhea-AI Summary
HippoFi partners with Zimmer Biomet to introduce a synthetic biomaterial for bone growth under PUR Biologics, leading to FDA clearance and global license. Joint commercialization research agreement established. Positive impact on stock price expected.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.61%
Tags
none
-
News
HippoFi To Announce Strategic Alliance With Orthopedic Industry Leader
Rhea-AI Summary
HippoFi to announce strategic partnership and asset acquisition with top 5 global leader in orthopedic industry
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.59%
Tags
none
-
News
US Patent Office Issues New Patent to PUR Biologics for Advanced Cartilage Regeneration and Arthritis Solutions
Rhea-AI Summary
ORHB - PUR Biologics Announces Patent for iPSC-ECM, Revolutionizing Cartilage Repair Market. With the global cartilage repair market projected to reach $3.5 billion by 2028, the demand for effective cartilage regeneration solutions has never been more pronounced. PUR Biologics is well positioned to capture a significant share of this lucrative market segment.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-26.67%
Tags
none
News
HippoFi Finalizes an Exclusive Strategic Partnership with International Biomedical Manufacturing Company, BPB Medica
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.62%
Tags
partnership
Stock ORHB logo
ORHUB INC

OTC:ORHB

ORHB Rankings

N/A Ranked by Market Cap
N/A Ranked by Stock Gains
N/A Ranked by Dividends

ORHB Stock Data

5.72M
0%
Custom Computer Programming Services
Professional, Scientific, and Technical Services
Link
United States of America
Phoenix

About ORHB

orhub, inc. provides surgical software focusing on real-time surgical data analytics. the company's suite of products serves the needs of the health care industry, hospitals, patients, the government, and medical device vendors. the company provides a cloud-based software solution that captures information before, during, and after surgery. its software applications allow hospitals and medical device vendors to utilize web-enabled device to create an anatomical graphic depiction during surgery. the company is based in phoenix, arizona.